Notice of Senior Executive Service Performance Review Board Membership, 71793-71794 [2012-29033]

Download as PDF Federal Register / Vol. 77, No. 233 / Tuesday, December 4, 2012 / Notices —Risk Assumed —Leases —Public Private Partnerships —Technical Agenda, and —Any other topics as needed. Any interested person may attend the meetings as an observer. Board discussion and reviews are open to the public. GAO Building security requires advance notice of your attendance. Please notify FASAB of your planned attendance by calling 202–512–7350 at least one day prior to the respective meeting. FOR FURTHER INFORMATION CONTACT: PERSON TO CONTACT FOR INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. Shawn Woodhead Werth, Secretary and Clerk of the Commission. [FR Doc. 2012–29309 Filed 11–30–12; 11:15 am] BILLING CODE 6715–01–P FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company mstockstill on DSK4VPTVN1PROD with Wendy Payne, Executive Director, at (202) 512–7350. The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and Authority: Federal Advisory Committee § 225.41 of the Board’s Regulation Y (12 Act, Public Law 92–463. CFR 225.41) to acquire shares of a bank Dated: November 28, 2012. or bank holding company. The factors Charles Jackson, that are considered in acting on the Federal Register Liaison Officer. notices are set forth in paragraph 7 of [FR Doc. 2012–29247 Filed 12–3–12; 8:45 am] the Act (12 U.S.C. 1817(j)(7)). BILLING CODE 1610–02–P The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices FEDERAL ELECTION COMMISSION also will be available for inspection at the offices of the Board of Governors. Sunshine Act Meeting Interested persons may express their views in writing to the Reserve Bank AGENCY: Federal Election Commission. indicated for that notice or to the offices DATE & TIME: Thursday, December 6, of the Board of Governors. Comments 2012 at 10:00 a.m. must be received not later than PLACE: 999 E Street NW., Washington, December 19, 2012. DC (Ninth Floor). A. Federal Reserve Bank of Richmond STATUS: This meeting will be open to the (Adam M. Drimer, Assistant Vice public. President) 701 East Byrd Street, ITEMS TO BE DISCUSSED: Richmond, Virginia 23261–4528: Correction and Approval of the Minutes 1. Paul Jerome Mitchell, Columbia, for the Meeting of November 15, 2012 South Carolina; to acquire voting shares Draft Advisory Opinion 2012–34: of SCCB Financial Corporation, and Freedom PAC and Friends of Mike H thereby indirectly acquire voting shares Draft Advisory Opinion 2012–35: Global of South Carolina Community Bank, Transaction Services Group, Inc. both in Columbia, South Carolina. Draft Advisory Opinion 2012–36: Green Board of Governors of the Federal Reserve Party of Connecticut System, November 29, 2012. Draft Advisory Opinion 2012–37: Margaret McCloskey Shanks, Yamaha Motor Corporation, U.S.A. Deputy Secretary of the Board. Proposed Final Audit Report on [FR Doc. 2012–29200 Filed 12–3–12; 8:45 am] Minnesota Democratic-Farmer-Labor BILLING CODE 6210–01–P Party (A09–08) Audit Division Recommendation Memorandum on McCain-Palin 2008, FEDERAL RESERVE SYSTEM Inc. and McCain-Palin Compliance Fund, Inc. Formations of, Acquisitions by, and Notice of Proposed Rulemaking: Limited Mergers of Bank Holding Companies Liability Partnerships Management and Administrative The companies listed in this notice Matters have applied to the Board for approval, pursuant to the Bank Holding Company Individuals who plan to attend and Act of 1956 (12 U.S.C. 1841 et seq.) require special assistance, such as sign (BHC Act), Regulation Y (12 CFR part language interpretation or other 225), and all other applicable statutes reasonable accommodations, should and regulations to become a bank contact Shawn Woodhead Werth, holding company and/or to acquire the Secretary and Clerk, at (202) 694–1040, assets or the ownership of, control of, or at least 72 hours prior to the meeting the power to vote shares of a bank or date. VerDate Mar<15>2010 17:31 Dec 03, 2012 Jkt 229001 PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 71793 bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than December 28, 2012. A. Federal Reserve Bank of San Francisco (Kenneth Binning, Vice President, Applications and Enforcement) 101 Market Street, San Francisco, California 94105–1579: 1. First Northwest Bancorp, Port Angeles, Washington; to become a bank holding company upon the conversion of First Federal Savings and Loan Association of Port Angeles, Port Angeles, Washington, from a mutual to stock savings bank. Board of Governors of the Federal Reserve System, November 29, 2012. Margaret McCloskey Shanks, Deputy Secretary of the Board. [FR Doc. 2012–29201 Filed 12–3–12; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Senior Executive Service Performance Review Board Membership The Agency for Healthcare Research and Quality (AHRQ) announces the appointment of members to the AHRQ Senior Executive Service (SES) Performance Review Board (PRB). This action is being taken in accordance with 5 U.S.C. 4314(c)(4), which requires notice of appointment of members to performance review boards to be published in the Federal Register. E:\FR\FM\04DEN1.SGM 04DEN1 71794 Federal Register / Vol. 77, No. 233 / Tuesday, December 4, 2012 / Notices Members of the PRB are appointed in a manner that will ensure consistency, stability and objectivity in the SES performance appraisals. The function of the PRB is to make recommendations to the Director, AHRQ, relating to the performance of senior executives in the Agency. The following persons will serve on the AHRQ SES Performance Review Board: Irene Fraser Stephen B. Cohen William Munier David Meyers Michael Fitzmaurice Phyllis Zucker Mark Handelman Jean Slutsky For further information about the AHRQ Performance Review Board, contact Ms. Alison Reinheimer, Office of Performance, Accountability, Resources, and Technology, Agency for Healthcare Research and Quality, 540 Gaither Road, Suite 4010, Rockville, Maryland 20850. Dated: November 26, 2012. Carolyn M. Clancy, Director, AHRQ. [FR Doc. 2012–29033 Filed 12–3–12; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–13–0840] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call (404) 639–7570 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. mstockstill on DSK4VPTVN1PROD with Proposed Project Formative Research and Tool Development—(OMB # 0920–0840, Exp. 1/31/2013)—Revision—National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). VerDate Mar<15>2010 17:31 Dec 03, 2012 Jkt 229001 Background and Brief Description The Centers for Disease Control and Prevention request approval for a revision and a 3 year approval for the previously approved Formative Research and Tool Development. This information collection request has been revised to include one additional type of formative research information collection activity, additional detail regarding the previously approved categories of formative research, and instrument testing for data collection activities used to inform many aspects of surveillance, communications, health promotion, and research project development for NCHHSTP’s 4 priority diseases (HIV/AIDS, sexually transmitted diseases/infections (STD/ STI), viral hepatitis, and tuberculosis elimination. Formative research is the basis for developing effective strategies including communication channels, for influencing behavior change. It helps researchers identify and understand the characteristics—interests, behaviors and needs—of target populations that influence their decisions and actions. Formative research is integral in developing programs as well as improving existing and ongoing programs. Formative research also looks at the community in which a public health intervention is being or will be implemented and helps the project staff understand the interests, attributes and needs of different populations and persons in that community. Formative research is research that occurs before a program is designed and implemented, or while a program is being conducted. Formative research is an integral part of developing programs or adapting programs that deal with the complexity of behaviors, social context, cultural identities, and health care that underlie the epidemiology of HIV/AIDS, viral hepatitis, STDs, and TB in the U.S. CDC conducts formative research to develop public-sensitive communication messages and user friendly tools prior to developing or recommending interventions, or care. Sometimes these studies are entirely behavioral but most often they are cycles of interviews and focus groups designed to inform the development of a product. Products from these formative research studies will be used for prevention of HIV/AIDS, Sexually Transmitted Infections (STI), viral Hepatitis, and Tuberculosis. Findings from these studies may also be presented as evidence to diseasespecific National Advisory Committees, to support revisions to recommended PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 prevention and intervention methods, as well as new recommendations. Much of CDC’s health communication takes place within campaigns that have fairly lengthy planning periods— timeframes that accommodate the standard Federal process for approving data collections. Short term qualitative interviewing and cognitive research techniques have previously proven invaluable in the development of scientifically valid and populationappropriate methods, interventions, and instruments. This request includes studies investigating the utility and acceptability of proposed sampling and recruitment methods, intervention contents and delivery, questionnaire domains, individual questions, and interactions with project staff or electronic data collection equipment. These activities will also provide information about how respondents answer questions and ways in which question response bias and error can be reduced. This request also includes collection of information from public health programs to assess needs related to initiation of a new program activity or expansion or changes in scope or implementation of existing program activities to adapt them to current needs. The information collected will be used to advise programs and provide capacity-building assistance tailored to identified needs. Overall, these development activities are intended to provide information that will increase the success of the surveillance or research projects through increasing response rates and decreasing response error, thereby decreasing future data collection burden to the public. The studies that will be covered under this request will include one or more of the following investigational modalities: (1) structured and qualitative interviewing for surveillance, research, interventions and material development, (2) cognitive interviewing for development of specific data collection instruments, (3) methodological research (4) usability testing of technology-based instruments and materials, (5) field testing of new methodologies and materials, (6) investigation of mental models for health decision-making, to inform health communication messages, and (7) organizational needs assessment to support development of capacity. Respondents who will participate in individual and group interviews (qualitative, cognitive, and computer assisted development activities) are selected purposively from those who respond to recruitment advertisements. E:\FR\FM\04DEN1.SGM 04DEN1

Agencies

[Federal Register Volume 77, Number 233 (Tuesday, December 4, 2012)]
[Notices]
[Pages 71793-71794]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-29033]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Senior Executive Service Performance Review Board 
Membership

    The Agency for Healthcare Research and Quality (AHRQ) announces the 
appointment of members to the AHRQ Senior Executive Service (SES) 
Performance Review Board (PRB). This action is being taken in 
accordance with 5 U.S.C. 4314(c)(4), which requires notice of 
appointment of members to performance review boards to be published in 
the Federal Register.

[[Page 71794]]

    Members of the PRB are appointed in a manner that will ensure 
consistency, stability and objectivity in the SES performance 
appraisals. The function of the PRB is to make recommendations to the 
Director, AHRQ, relating to the performance of senior executives in the 
Agency.
    The following persons will serve on the AHRQ SES Performance Review 
Board:

Irene Fraser
Stephen B. Cohen
William Munier
David Meyers
Michael Fitzmaurice
Phyllis Zucker
Mark Handelman
Jean Slutsky

    For further information about the AHRQ Performance Review Board, 
contact Ms. Alison Reinheimer, Office of Performance, Accountability, 
Resources, and Technology, Agency for Healthcare Research and Quality, 
540 Gaither Road, Suite 4010, Rockville, Maryland 20850.

    Dated: November 26, 2012.
Carolyn M. Clancy,
Director, AHRQ.
[FR Doc. 2012-29033 Filed 12-3-12; 8:45 am]
BILLING CODE 4160-90-M